Notably, the SWELL1 small-molecule inducer SN-401 significantly improves the NAFLD phenotype of ob/ob and db/db diabetic mice, including reducing liver weight and triglyceride concentration and alleviating liver steatosis and cell damage (Gunasekar et al., 2022). This evidence concerns the gene LRRC8A and metabolic dysfunction-associated steatotic liver disease.